Ulcerative Colitis and Herbal Medicine: Pathophysiological Mechanisms, Preclinical Evidence, Clinical Evidence, and Therapeutic Opportunities

Authors

  • Maithili Pote Department of Pharmacognosy, Bharati Vidyapeeth Deemed to be University, Poona College of Pharmacy, Erandwane, Pune, Maharashtra 411038, India
    • Kaumudee Bodas Department of Pharmacognosy, Bharati Vidyapeeth Deemed to be University, Poona College of Pharmacy, Erandwane, Pune, Maharashtra 411038, India

      DOI:

      https://doi.org/10.61280/journalmedicinalplants.v2i4.315

      Keywords:

      Ulcerative colitis (UC), Chronic inflammation, Inflammatory bowel disease (IBD), Complementary and alternative medicine, Mucosal healing, Antioxidant, Anti-inflammatory, Immunomodulatory effect

      Abstract

      Ulcerative colitis (UC) is a chronic inflammatory disease of the colon that usually starts in the rectum and is caused by genetic vulnerability, poor epithelial barrier function, microbial dysbiosis, and dysregulated immunological responses. Current pharmacological treatments relieve symptoms but are commonly linked with adverse effects, incomplete remission, and relapse, driving growing interest in herbal therapy as a multi-targeted, safer therapeutic option.This review synthesizes preclinical and clinical evidence on plant species with anti-colitic potential, such as Vitis vinifera, Cocos nucifera, Arctium lappa, Pimpinella candolleana, Ziziphus jujuba, Juglans regia, Terminalia chebula, Cordia dichotoma, and others, focusing on their mechanisms of action and translational relevance. Most species had preclinical investigations, but only a handful had clinical data.These plants exert anti-colitic effects via regulating nuclear factor kappa B, cyclooxygenase-2, tumor necrosis factor-alpha, interleukin-6, interleukin-13, and oxidative stress pathways. Flavonoids, polyphenols, terpenoids, and polysaccharides are bioactive ingredients that repair antioxidant defenses, promote mucosal healing, and regulate the gut flora. Preliminary clinical data and commercial herbal preparations provide additional support for translational potential.Herbal interventions offer a holistic approach to UC by addressing inflammation, oxidative stress, and microbial imbalance; however, clinical validation, extract standardization, and safety testing remain essential before mainstream integration.

      Views: 279Downloads: 115

      Downloads

      Download data is not yet available.

      Author Biographies

      • Maithili Pote, Department of Pharmacognosy, Bharati Vidyapeeth Deemed to be University, Poona College of Pharmacy, Erandwane, Pune, Maharashtra 411038, India

        Student

      • Kaumudee Bodas, Department of Pharmacognosy, Bharati Vidyapeeth Deemed to be University, Poona College of Pharmacy, Erandwane, Pune, Maharashtra 411038, India

        Assistant Professor

      References

      Gajendran M, Loganathan P, Jimenez G, et al. A comprehensive review and update on ulcerative colitis. Dis Mon. 2019;65(12):100851. doi:10.1016/j.disamonth.2019.02.004

      Ferretti F, Cannatelli R, Monico MC, Maconi G, Ardizzone S. An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis. J Clin Med. 2022;11(9):2302. doi:10.3390/jcm11092302

      Vestergaard MV, Nøhr AK, Allin KH, et al. HLA-DRB1*01:03 and Severe Ulcerative Colitis. JAMA. 2024;332(22):1941-1943. doi:10.1001/jama.2024.20429

      Kaymanova Kamila Imamovna Bukhara State Medical Institute. modern theories in the etiology of ulcerative colitis: a literature review. Modern American Journal of Medical and Health Sciences. 2025;volume 02(Issue 02):39-49.

      Arakhamia T, Lee CE, Carlomagno Y, et al. Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains. Cell. 2021;184(25):6207-6210. doi:10.1016/j.cell.2021.11.029

      Noviello D, Mager R, Roda G, Borroni RG, Fiorino G, Vetrano S. The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges. Front Immunol. 2021;12:611256. doi:10.3389/fimmu.2021.611256

      Stange EF. Mitochondria in Ulcerative Colitis. Cell Mol Gastroenterol Hepatol. 2021;12(1):352-353. doi:10.1016/j.jcmgh.2021.02.006

      Priyanka Tanwar1,et al. A review on Ulcerative Colitis: Epidemiology, Risk Factors, Pathophysiology, Diagnosis, Clinical Management and Treatment Modalities. International Journal of Enhanced Research in Medicines & Dental Care (IJERMDC). 2023;10(2).

      Weisman MH, Oleg Stens, Seok Kim H, Hou JK, Miller FW, Dillon CF. Inflammatory Bowel Disease Prevalence: Surveillance data from the U.S. National Health and Nutrition Examination Survey. Prev Med Rep. 2023;33:102173. doi:10.1016/j.pmedr.2023.102173

      Landeira M, Markert M, Guedes S, Balijepalli C, Druyts E, Nielsen L. P1186 Global epidemiology of Ulcerative Colitis: A systematic literature review from 2014 - 2025. J Crohns Colitis. 2026;20(Supplement_1). doi:10.1093/ecco-jcc/jjaf231.1367

      Marsool MDM, Vora N, Marsool ADM, et al. Ulcerative colitis: Addressing the manifestations, the role of fecal microbiota transplantation as a novel treatment option and other therapeutic updates. Disease-a-Month. 2023;69(11):101606. doi:10.1016/j.disamonth.2023.101606

      Suraj DS, Patil DP, Sangolkar D, Rane N. History and Prevalence of Ulcerative Colitis: A Review. International Journal of Innovative Research in Medical Science. 2024;9(04):187-191. doi:10.23958/ijirms/vol09-i04/1844

      Andrews MA, Sadiq SM, Siu R, Chaudhari D. 12 Asymptomatic Double Small Bowel Intussusception in a Patient With Ulcerative Colitis Flare: A Rare and Incidental Finding. American Journal of Gastroenterology. 2025;120(12S):S3-S4. doi:10.14309/01.ajg.0001172472.31677.51

      Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79(2):516-537. doi:10.1016/j.jhep.2023.03.017

      Veral MA, Pickup RW, Roy M, Sanderson J, Agrawal G, Atkinson PM. Geographic distribution of inflammatory bowel disease in the UK: A spatially explicit survey. PLoS One. 2025;20(8):e0329317. doi:10.1371/journal.pone.0329317

      Popov J, Caputi V, Nandeesha N, Rodriguez DA, Pai N. Microbiota-Immune Interactions in Ulcerative Colitis and Colitis Associated Cancer and Emerging Microbiota-Based Therapies. Int J Mol Sci. 2021;22(21). doi:10.3390/ijms222111365

      Quansah E, Gardey E, Ramoji A, et al. Intestinal epithelial barrier integrity investigated by label-free techniques in ulcerative colitis patients. Sci Rep. 2023;13(1):2681. doi:10.1038/s41598-023-29649-y

      Koeninger L, Armbruster NS, Brinch KS, et al. Human β-Defensin 2 Mediated Immune Modulation as Treatment for Experimental Colitis. Front Immunol. 2020;11:93. doi:10.3389/fimmu.2020.00093

      Bu F, Chen K, Chen S, Jiang Y. Gut microbiota and intestinal immunity interaction in ulcerative colitis and its application in treatment. Front Cell Infect Microbiol. 2025;15:1565082. doi:10.3389/fcimb.2025.1565082

      Ren K, Yong C, Jin Y, et al. Unraveling the microbial mysteries: gut microbiota’s role in ulcerative colitis. Front Nutr. 2025;12. doi:10.3389/fnut.2025.1519974

      Popov J, Caputi V, Nandeesha N, Rodriguez DA, Pai N. Microbiota-Immune Interactions in Ulcerative Colitis and Colitis Associated Cancer and Emerging Microbiota-Based Therapies. Int J Mol Sci. 2021;22(21):11365. doi:10.3390/ijms222111365

      Filardy AA, Ferreira JRM, Rezende RM, Kelsall BL, Oliveira RP. The intestinal microenvironment shapes macrophage and dendritic cell identity and function. Immunol Lett. 2023;253:41-53. doi:10.1016/j.imlet.2023.01.003

      Kałużna A, Olczyk P, Komosińska-Vassev K. The Role of Innate and Adaptive Immune Cells in the Pathogenesis and Development of the Inflammatory Response in Ulcerative Colitis. J Clin Med. 2022;11(2):400. doi:10.3390/jcm11020400

      Abraham C, Abreu MT, Turner JR. Pattern Recognition Receptor Signaling and Cytokine Networks in Microbial Defenses and Regulation of Intestinal Barriers: Implications for Inflammatory Bowel Disease. Gastroenterology. 2022;162(6):1602-1616.e6. doi:10.1053/j.gastro.2021.12.288

      Zhang Y, Liu J, Wang C, Liu J, Lu W. Toll-Like Receptors Gene Polymorphisms in Autoimmune Disease. Front Immunol. 2021;12:672346. doi:10.3389/fimmu.2021.672346

      Laurindo LF, Santos AR de O dos, Carvalho ACA de, et al. Phytochemicals and Regulation of NF-kB in Inflammatory Bowel Diseases: An Overview of In Vitro and In Vivo Effects. Metabolites. 2023;13(1):96. doi:10.3390/metabo13010096

      Hoffmann A, Cheng G, Baltimore D. NF-κB: master regulator of cellular responses in health and disease. Immunity & Inflammation. 2025;1(1):2. doi:10.1007/s44466-025-00014-0

      Fuss IJ, Heller F, Boirivant M, et al. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. Journal of Clinical Investigation. 2004;113(10):1490-1497. doi:10.1172/JCI19836

      Usman Y, Ptak CP, Cohran VC, Nolan BE, Ahmed A, Khanolkar A. Case Report: Novel IL10RB variant causing very early onset-inflammatory bowel disease. Front Immunol. 2025;16. doi:10.3389/fimmu.2025.1655475

      Zhu Y, Yang S, Zhao N, et al. CXCL8 chemokine in ulcerative colitis. Biomedicine & Pharmacotherapy. 2021;138:111427. doi:10.1016/j.biopha.2021.111427

      Liang Y, Li Y, Lee C, Yu Z, Chen C, Liang C. Ulcerative colitis: molecular insights and intervention therapy. Molecular biomedicine. 2024;5(1):42. doi:10.1186/s43556-024-00207-w

      Møller SR, Ekholm O, Christensen AI. Trends in the use of complementary and alternative medicine between 1987 and 2021 in Denmark. BMC Complement Med Ther. 2024;24(1):23. doi:10.1186/s12906-023-04327-8

      Ding X, Meng PF, Ma XX, Yue JY, Li LP, Xu LR. Akkermansia muciniphila and herbal medicine in immune-related diseases: current evidence and future perspectives. Frontiers in Microbiomes. 2024;3. doi:10.3389/frmbi.2024.1276015

      Niknami E, Sajjadi SE, Talebi A, Minaiyan M. Protective Effect of Vitis vinifera (Black Grape) Seed Extract and Oil on Acetic Acid-Induced Colitis in Rats. Int J Prev Med. 2020;11(1). doi:10.4103/ijpvm.IJPVM_362_19

      Hemmati AA, Foroozan M, Houshmand G, Moosavi ZB, Bahadoram M, Maram NS. The Topical Effect of Grape Seed Extract 2% Cream on Surgery Wound Healing. Glob J Health Sci. 2014;7(3). doi:10.5539/gjhs.v7n3p52

      Nassiri‐Asl M, Hosseinzadeh H. Review of the pharmacological effects of Vitis vinifera (Grape) and its bioactive compounds. Phytotherapy Research. 2009;23(9):1197-1204. doi:10.1002/ptr.2761

      Filocamo A, Bisignano C, Mandalari G, Navarra M. In Vitro Antimicrobial Activity and Effect on Biofilm Production of a White Grape Juice ( Vitis vinifera ) Extract. Evidence-Based Complementary and Alternative Medicine. 2015;2015:1-5. doi:10.1155/2015/856243

      Abd El Ghany M, Ramadan AH, Nagib R, EL-Azaly F. Comparative Study Between Virgin Coconut Oil and Omeprazole Drug on Ulcerative Colitis in Experimental Rats. Journal of Food and Dairy Sciences. 2021;12(2):43-48. doi:10.21608/jfds.2021.62433.1016

      Hosny KM, Alhakamy NA, Sindi AM, Khallaf RA. Coconut Oil Nanoemulsion Loaded with a Statin Hypolipidemic Drug for Management of Burns: Formulation and In Vivo Evaluation. Pharmaceutics. 2020;12(11):1061. doi:10.3390/pharmaceutics12111061

      Ni Made Rika Trismayanti 1 Kusworini Handono 2 Dian Handayani 3 Umi Kalsum 4. Virgin Coconut Oil Supplementation as Ulcerative Colitis Prevention, Does it work? Clinical Correlation. Journal of Medicinal and Chemical Sciences. 2023;6(12):3178-3187.

      Dinarello CA. Proinflammatory Cytokines. Chest. 2000;118(2):503-508. doi:10.1378/chest.118.2.503

      Ma Q, Zhang X, Xu X, et al. Long‐term oral administration of burdock fructooligosaccharide alleviates DSS‐induced colitis in mice by mediating anti‐inflammatory effects and protection of intestinal barrier function. Immun Inflamm Dis. 2023;11(11). doi:10.1002/iid3.1092

      Zhang R, Zhang Q, Chen Y, et al. Combined treatment with Rg1 and adipose-derived stem cells alleviates DSS-induced colitis in a mouse model. Stem Cell Res Ther. 2022;13(1):272. doi:10.1186/s13287-022-02940-x

      Hu Y, Guan X, He Z, et al. Apigenin-7-O-glucoside alleviates DSS-induced colitis by improving intestinal barrier function and modulating gut microbiota. J Funct Foods. 2023;104:105499. doi:10.1016/j.jff.2023.105499

      Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol. 2014;14(3):141-153. doi:10.1038/nri3608

      Wang YJ, Li QM, Zha XQ, Luo JP. Intervention and potential mechanism of non-starch polysaccharides from natural resources on ulcerative colitis: A review. Int J Biol Macromol. 2022;210:545-564. doi:10.1016/j.ijbiomac.2022.04.208

      Meng Y, Ma Q, Xu X, et al. Burdock fructooligosaccharide ameliorates the hypercholesterolemia and vascular inflammation in mice by regulating cholesterol homeostasis and anti-inflammatory properties. J Funct Foods. 2023;107:105678. doi:10.1016/j.jff.2023.105678

      Liu X, Xiao H, Luo M, et al. Anti-inflammatory and protective effects of Pimpinella candolleana on ulcerative colitis in rats: a comprehensive study of quality, chemical composition, and molecular mechanisms. Front Pharmacol. 2024;15. doi:10.3389/fphar.2024.1328977

      Jia F, Yang Q, Yao L, et al. Exploring the Potential Mechanism of Liupao Tea Using UPLC-Q-TOF/MS and Network Pharmacology. Pharmaceuticals. 2025;18(3):294. doi:10.3390/ph18030294

      Olivotto E, Otero M, Astolfi A, et al. IKKα/CHUK Regulates Extracellular Matrix Remodeling Independent of Its Kinase Activity to Facilitate Articular Chondrocyte Differentiation. PLoS One. 2013;8(9):e73024. doi:10.1371/journal.pone.0073024

      Adelaja A, Hoffmann A. Signaling Crosstalk Mechanisms That May Fine-Tune Pathogen-Responsive NFκB. Front Immunol. 2019;10. doi:10.3389/fimmu.2019.00433

      Bahrami S, Babaei N, Esmaeili Gouvarchin Ghaleh H, Mohajeri Borazjani J, Farzanehpour M. Anti-inflammatory activity of Ziziphus jujuba hydroalcoholic extract in acetic acid-induced ulcerative colitis model. J Complement Integr Med. 2024;21(4):481-489. doi:10.1515/jcim-2024-0178

      Falahi E, Delshadian Z, Ahmadvand H, Shokri Jokar S. Head space volatile constituents and antioxidant properties of five traditional Iranian wild edible plants grown in west of Iran. AIMS Agriculture and Food. 2019;4(4):1034-1053. doi:10.3934/agrfood.2019.4.1034

      Chen S, Wu X, Yu Z. Juglone Suppresses Inflammation and Oxidative Stress in Colitis Mice. Front Immunol. 2021;12. doi:10.3389/fimmu.2021.674341

      Seetha A, Devaraj H, Sudhandiran G. Indomethacin and juglone inhibit inflammatory molecules to induce apoptosis in colon cancer cells. J Biochem Mol Toxicol. 2020;34(2). doi:10.1002/jbt.22433

      Dou X, Gao N, Yan D, Shan A. Sodium Butyrate Alleviates Mouse Colitis by Regulating Gut Microbiota Dysbiosis. Animals. 2020;10(7):1154. doi:10.3390/ani10071154

      Dong WR, Li YY, Liu TT, Zhou G, Chen YX. Ethyl acetate extract of Terminalia chebula alleviates DSS-induced ulcerative colitis in C57BL/6 mice. Front Pharmacol. 2023;14. doi:10.3389/fphar.2023.1229772

      Chamanara M, Rashidian A, Mehr SE, et al. Melatonin ameliorates TNBS-induced colitis in rats through the melatonin receptors: involvement of TLR4/MyD88/NF-κB signalling pathway. Inflammopharmacology. 2019;27(2):361-371. doi:10.1007/s10787-018-0523-8

      Zhou P, Lai J, Li Y, et al. Methyl Gallate Alleviates Acute Ulcerative Colitis by Modulating Gut Microbiota and Inhibiting TLR4/NF-κB Pathway. Int J Mol Sci. 2022;23(22):14024. doi:10.3390/ijms232214024

      Ganjare A, Raut N. Phytochemical and pharmacological properties of Cordia dichotoma (Bhokar): A short review. Asian J Pharm Pharmacol. 2019;5(5):858-865. doi:10.31024/ajpp.2019.5.5.1

      Otani T, Yamaguchi K, Scherl E, et al. Levels of NAD + -dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-α. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2006;290(2):G361-G368. doi:10.1152/ajpgi.00348.2005

      Li YY, Cui Y, Dong WR, Liu TT, Zhou G, Chen YX. Terminalia bellirica Fruit Extract Alleviates DSS-Induced Ulcerative Colitis by Regulating Gut Microbiota, Inflammatory Mediators, and Cytokines. Molecules. 2023;28(15). doi:10.3390/molecules28155783

      Liu YJ, Xu WH, Fan LM, et al. Polydatin alleviates DSS- and TNBS-induced colitis by suppressing Th17 cell differentiation via directly inhibiting STAT3. Phytother Res. 2022;36(9):3662-3671. doi:10.1002/ptr.7533

      Li WY, Liu JY, Wang ZX, et al. Sinapic Acid Attenuates Chronic DSS-Induced Intestinal Fibrosis in C57BL/6J Mice by Modulating NLRP3 Inflammasome Activation and the Autophagy Pathway. ACS Omega. 2024;9(1):1230-1241. doi:10.1021/acsomega.3c07474

      Han H, Gao M, Wang F, et al. Protective effects of patchouli alcohol against DSS-induced ulcerative colitis. Sci Rep. 2024;14(1):16745. doi:10.1038/s41598-024-66259-8

      Wu B, Zhou Q, He Z, Wang X, Sun X, Chen Y. Protective Effect of the Abelmoschus manihot Flower Extract on DSS-Induced Ulcerative Colitis in Mice. Evid Based Complement Alternat Med. 2021;2021:7422792. doi:10.1155/2021/7422792

      Karthick Kannan RAJENDRAN 1 * I. Therapeutic effect of Anethum graveolens L. (Dill) seed extract for the treatment of dextran sodium sulfate (DSS) induced ulcerative colitis in Wistar rats. Journal of Research in Pharmacy. Published online September 2023:770-780.

      Jia Y, Liu X, Gao X, et al. Plantamajoside alleviates DSS-induced ulcerative colitis by modulating gut microbiota, upregulating CBS, and inhibiting NF-κB. Phytomedicine. 2025;143:156827. doi:10.1016/j.phymed.2025.156827

      Mondal S, Ganguly A, Nandi A, et al. Network pharmacology and molecular docking reveal multi-target mechanisms of Butea monosperma stem bark extract in ulcerative colitis. Sci Rep. 2025;15(1):40302. doi:10.1038/s41598-025-24091-8

      Shin JM, Son YJ, Ha IJ, et al. Artemisia argyi extract alleviates inflammation in a DSS-induced colitis mouse model and enhances immunomodulatory effects in lymphoid tissues. BMC Complement Med Ther. 2022;22(1):64. doi:10.1186/s12906-022-03536-x

      Wang J, Cao W, Ji T, et al. Gut microbiota and transcriptome profiling revealed the protective effect of aqueous extract of Tetrastigma hemsleyanum leaves on ulcerative colitis in mice. Curr Res Food Sci. 2023;6:100426. doi:10.1016/j.crfs.2022.100426

      Han H, Gao M, Wang F, et al. Protective effects of patchouli alcohol against DSS-induced ulcerative colitis. Sci Rep. 2024;14(1):16745. doi:10.1038/s41598-024-66259-8

      Mandlik D, Joshi R, Kalsekar C, et al. Network pharmacology and molecular docking of Nelumbo nucifera Gaertn. to reveal the pharmacological mechanisms in treating TNBS-induced ulcerative colitis in rats. In Silico Pharmacol. 2025;13(3):180. doi:10.1007/s40203-025-00458-7

      Li H, Ruan J, Huang J, et al. Pomegranate peel and ellagic acid attenuate ulcerative colitis by targeting AKR1B1/B3 to inhibit NLRP3. Phytomedicine. 2025;149:157587. doi:10.1016/j.phymed.2025.157587

      Huang C, Luo X, Li L, et al. Glycyrrhiza Polysaccharide Alleviates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice. Evidence-Based Complementary and Alternative Medicine. 2022;2022:1-9. doi:10.1155/2022/1345852

      Peng KY, Gu JF, Su SL, et al. Salvia miltiorrhiza stems and leaves total phenolic acids combination with tanshinone protect against DSS-induced ulcerative colitis through inhibiting TLR4/PI3K/AKT/mTOR signaling pathway in mice. J Ethnopharmacol. 2021;264:113052. doi:10.1016/j.jep.2020.113052

      Mao N, Yu Y, He J, et al. Matrine Ameliorates DSS-Induced Colitis by Suppressing Inflammation, Modulating Oxidative Stress and Remodeling the Gut Microbiota. Int J Mol Sci. 2024;25(12). doi:10.3390/ijms25126613

      Xiong M, Kuang W, Liu Z, et al. Quercetin alleviates ulcerative colitis via regulating gut microbiota and tryptophan metabolism. mSystems. 2025;10(12):e0070325. doi:10.1128/msystems.00703-25

      Zhang H, Wang Y, Su Y, Fang X, Guo W. The alleviating effect and mechanism of Bilobalide on ulcerative colitis. Food Funct. 2021;12(14):6226-6239. doi:10.1039/D1FO01266E

      Ghasemi-Dehnoo M, Safari AA, Rahimi-Madiseh M, Lorigooini Z, Moradi MT, Amini-Khoei H. Anethole Ameliorates Acetic Acid-Induced Colitis in Mice: Anti-Inflammatory and Antioxidant Effects. Evid Based Complement Alternat Med. 2022;2022:9057451. doi:10.1155/2022/9057451

      Han H, Sun W, Feng L, et al. Differential relieving effects of shikonin and its derivatives on inflammation and mucosal barrier damage caused by ulcerative colitis. PeerJ. 2021;9:e10675. doi:10.7717/peerj.10675

      Hasan S, Ghani N, Zhao X, Good J, Liu C ju. Exogenous pyruvate is therapeutic against colitis by targeting cytosolic phospholipase A2. Genes Dis. 2025;12(5):101571. doi:10.1016/j.gendis.2025.101571

      Sun X, Zhang Y, Cheng G, et al. Berberine improves DSS-induced colitis in mice by modulating the fecal-bacteria-related bile acid metabolism. Biomed Pharmacother. 2023;167:115430. doi:10.1016/j.biopha.2023.115430

      Liu J, Yang C, Wu Z, et al. Gardenia jasminoides Ellis Fruit Extracts Attenuated Colitis in 2,4,6-Trinitrobenzenesulfonic Acid-Induced Rats. Evidence-Based Complementary and Alternative Medicine. 2021;2021:1-11. doi:10.1155/2021/9920379

      He X, Luan F, Yang Y, et al. Passiflora edulis: An Insight Into Current Researches on Phytochemistry and Pharmacology. Front Pharmacol. 2020;11:617. doi:10.3389/fphar.2020.00617

      Liu K, Yin Y, Shi C, et al. Asiaticoside ameliorates DSS-induced colitis in mice by inhibiting inflammatory response, protecting intestinal barrier and regulating intestinal microecology. Phytother Res. 2024;38(4):2023-2040. doi:10.1002/ptr.8129

      Otu‐Boakye SA, Yeboah KO, Boakye‐Gyasi E, Oppong‐Kyekyeku J, Okyere PD, Osafo N. Acetic acid‐induced colitis modulating potential of total crude alkaloidal extract of Picralima nitida seeds in rats. Immun Inflamm Dis. 2023;11(5). doi:10.1002/iid3.855

      Banerjee R, Pal P, Penmetsa A, et al. Novel Bioenhanced Curcumin With Mesalamine for Induction of Clinical and Endoscopic Remission in Mild-to-Moderate Ulcerative Colitis. J Clin Gastroenterol. 2021;55(8):702-708. doi:10.1097/MCG.0000000000001416

      Matsuno Y, Torisu T, Umeno J, et al. One-year clinical efficacy and safety of indigo naturalis for active ulcerative colitis: a real-world prospective study. Intest Res. 2022;20(2):260-268. doi:10.5217/ir.2021.00124

      Zhou R, Huang Y, Tian C, Yang Y, Zhang Z, He K. Coptis chinensis and Berberine Ameliorate Chronic Ulcerative Colitis: An Integrated Microbiome-Metabolomics Study. Am J Chin Med (Gard City N Y). 2023;51(08):2195-2220. doi:10.1142/S0192415X23500945

      Shayesteh F, Haidari F, Shayesteh AA, Mohammadi-Asl J, Ahmadi-Angali K. Ginger in patients with active ulcerative colitis: a study protocol for a randomized controlled trial. Trials. 2020;21(1):278. doi:10.1186/s13063-020-4193-7

      Gupta I, Parihar A, Malhotra P, et al. Effects of Gum Resin of Boswellia serrata in Patients with Chronic Colitis. Planta Med. 2001;67(5):391-395. doi:10.1055/s-2001-15802

      Sandborn WJ, Targan SR, Byers VS, et al. Andrographis paniculata Extract (HMPL-004) for Active Ulcerative Colitis. American Journal of Gastroenterology. 2013;108(1):90-98. doi:10.1038/ajg.2012.340

      Baghizadeh A, Davati A, Heidarloo AJ, Emadi F, Aliasl J. Efficacy of Plantago major seed in management of ulcerative colitis symptoms: A randomized, placebo controlled, clinical trial. Complement Ther Clin Pract. 2021;44:101444. doi:10.1016/j.ctcp.2021.101444

      Downloads

      Published

      2026-08-30

      Citation

      Dimensions

      How to Cite

      Maithili Pote, & Kaumudee Bodas. (2026). Ulcerative Colitis and Herbal Medicine: Pathophysiological Mechanisms, Preclinical Evidence, Clinical Evidence, and Therapeutic Opportunities. International Journal of Pharmaceutical Research and Medicinal Plants, 2(4), 01-17. https://doi.org/10.61280/journalmedicinalplants.v2i4.315

      Share

      Similar Articles

      1-10 of 33

      You may also start an advanced similarity search for this article.